Confronto
Icatibant vs. Semax
Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.
Identità
Categoria
Ricerca (altro)
Ricerca (altro)
N. CAS
138614-30-9
80714-61-0
Peso molecolare
1304.52 g/mol
813.92 g/mol
Emivita
nessun dato
0.3 h
Sequenza
nessun dato
Met-Glu-His-Phe-Pro-Gly-ProMeccanismo d'azione
Icatibant
Icatibant competitively blocks the bradykinin B2 receptor. Because bradykinin mediates the vascular permeability, swelling and pain typical of hereditary angioedema, the blockade interrupts the acute attack.
Semax
Semax is a tetracosactide fragment analog without hormonal activity at MC2R. Proposed mechanisms include elevation of BDNF and NGF in hippocampus and striatum (in animal models), modulation of dopamine metabolism, and neuroprotective effects via anti-apoptotic pathways. A clear primary receptor is not established.
Base di evidenze
Evidenza più alta
RCT sull'uomo
Studio sull'uomo
Studi
1
4
di cui sull'uomo
1
2
Effetti registrati
1
3
Contraddizioni aperte
0
1
Eventi avversi documentati
1
1
Stato legale
Voci complete
Frequently asked questions
- What is the difference between Icatibant and Semax?
- Icatibant is classified as "Ricerca (altro)", while Semax is classified as "Ricerca (altro)". Icatibant: Icatibant is a synthetic decapeptide and selective antagonist of the bradykinin B2 receptor. It is approved to treat acute attacks of hereditary angioedema (HAE). Semax: Synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10). Approved in Russia for ischaemic stroke, cognitive function and ADHD in children. Western phase-3 trials absent. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Icatibant or Semax?
- The highest available evidence level is "RCT sull'uomo" for Icatibant and "Studio sull'uomo" for Semax. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Icatibant and Semax in Germany and the United States?
- Germania: Icatibant — Su prescrizione, Semax — Non approvato. Stati Uniti: Icatibant — Su prescrizione, Semax — Non approvato. These are factual summaries with source and review date on the individual pages.